rs3213671
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_006302.3(MOGS):c.664G>A(p.Gly222Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00033 in 1,614,192 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_006302.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000605 AC: 151AN: 249586Hom.: 1 AF XY: 0.000606 AC XY: 82AN XY: 135410
GnomAD4 exome AF: 0.000335 AC: 490AN: 1461884Hom.: 5 Cov.: 32 AF XY: 0.000315 AC XY: 229AN XY: 727244
GnomAD4 genome AF: 0.000282 AC: 43AN: 152308Hom.: 0 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74476
ClinVar
Submissions by phenotype
MOGS-congenital disorder of glycosylation Benign:1
- -
MOGS-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at